About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Ndor1
NADPH dependent diflavin oxidoreductase 1
MGI:1926047
285 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Adcy3tm2.1Drs/Adcy3tm2.1Drs
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129 * 129X1/SvJ * C57BL/6 		abnormal circadian sleep/wake cycle J:281839
abnormal nest building behavior J:281839
abnormal non-rapid eye movement sleep pattern J:281839
abnormal response to new environment J:281839
behavioral despair J:281839
decreased grooming behavior J:281839
hypoactivity J:281839
increased circulating corticosterone level J:281839
Armcx3tm1.1Eso/Y
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129S/SvEv * C57BL/6 		abnormal tumor morphology J:345411
decreased circulating alanine transaminase level J:345411
decreased circulating glucose level J:345411
decreased incidence of tumors by chemical induction J:345411
decreased susceptibility to diet-induced hepatic steatosis J:345411
decreased susceptibility to diet-induced obesity J:345411
decreased total body fat amount J:345411
improved glucose tolerance J:345411
increased circulating insulin level J:345411
increased food intake J:345411
increased insulin sensitivity J:345411
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S2/SvPas * C57BL/6 		abnormal coat/hair pigmentation J:123200
abnormal hair cycle J:123200
abnormal hair follicle development J:123200
abnormal hair follicle morphology J:123200
abnormal hair growth J:123200
abnormal hair shaft morphology J:123200
abnormal intestinal epithelium morphology J:123200
abnormal liver morphology J:123200
abnormal thymus involution J:123200
abnormal trabecular bone morphology J:123200
alopecia J:123200
cardiac fibrosis J:123200
decreased body weight J:123200
decreased cell proliferation J:123200
decreased compact bone thickness J:123200
decreased hair follicle number J:123200
decreased subcutaneous adipose tissue amount J:123200
decreased thymocyte number J:123200
delayed hair regrowth J:123200
kidney atrophy J:123200
kidney inflammation J:123200
kyphosis J:123200
osteoporosis J:123200
renal fibrosis J:123200
renal glomerulus atrophy J:123200
renal tubule atrophy J:123200
sebaceous gland hyperplasia J:123200
thick skin J:123200
Bmp1tm1.1Dgr/Bmp1tm1.1Dgr
Tll1tm2.1Dgr/Tll1tm2.1Dgr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * SJL 		abnormal bone marrow morphology J:210366
abnormal bone mineralization J:210366
abnormal enthesis morphology J:210366
abnormal femur morphology J:210366
abnormal long bone diaphysis morphology J:210366
abnormal long bone metaphysis morphology J:210366
abnormal osteoblast cell number J:210366
abnormal osteocyte dendritic process morphology J:210366
abnormal osteocyte lacuna morphology J:210366
abnormal osteocyte morphology J:210366
abnormal osteoid morphology J:210366
abnormal pelvic girdle bone morphology J:210366
abnormal tendon collagen fibril morphology J:210366
abnormal tibia morphology J:210366
abnormal trochanter morphology J:210366
decreased body length J:210366
decreased body size J:210366
decreased bone mineral density of femur J:210366
decreased bone strength J:210366
decreased bone trabecula number J:210366
decreased compact bone volume J:210366
decreased energy dissipated prior to femur fracture J:210366
decreased femur compact bone thickness J:210366
decreased femur maximal load J:210366
decreased femur stiffness J:210366
decreased femur yield load J:210366
decreased gonadal fat pad weight J:210366
decreased inguinal fat pad weight J:210366
disorganized long bone epiphyseal plate J:210366
femur fracture J:210366
fragile skeleton J:210366
normal homeostasis/metabolism phenotype J:210366
increased bone ossification J:210366
increased bone resorption J:210366
increased bone trabecular spacing J:210366
increased long bone epiphyseal plate size J:210366
increased osteoclast cell number J:210366
increased trabecular bone mass J:210366
increased width of hypertrophic chondrocyte zone J:210366
kyphosis J:210366
osteomalacia J:210366
rib fractures J:210366
short femur J:210366
slow postnatal weight gain J:210366
Ccbe1tm2.1Mlkn/Ccbe1tm2.1Mlkn
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129 * C57BL/6 		normal hematopoietic system phenotype J:196696
Cdk7Gt(D032B11)1.1Wrst/Cdk7Gt(D032B11)1.1Wrst
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvPas * 129S2/SvPas * C57BL/6 * SJL 		abnormal bone marrow morphology J:183925
abnormal coat/hair pigmentation J:183925
abnormal hair follicle bulge morphology J:183925
abnormal hair follicle morphology J:183925
abnormal kidney morphology J:183925
abnormal skin morphology J:183925
abnormal small intestine crypts of Lieberkuhn morphology J:183925
alopecia J:183925
decreased bone mineral content J:183925
decreased hematopoietic stem cell number J:183925
decreased small intestinal villus size J:183925
decreased subcutaneous adipose tissue amount J:183925
decreased telomere length J:183925
decreased trabecular bone mass J:183925
kyphosis J:183925
nephrocalcinosis J:183925
premature aging J:183925
thin dermal layer J:183925
weight loss J:183925
Clec16atm1.1Hhak/Clec16atm1.1Hhak
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 * SJL 		abnormal mitophagy J:214528
decreased oxygen consumption J:214528
Col1a1tm2(CAG-IDH2*R172K)Kkw/Col1a1+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6 		abnormal mitochondrial crista morphology J:209629
abnormal mitochondrial morphology J:209629
abnormal mitochondrial physiology J:209629
abnormal myocardial fiber mitochondrial morphology J:209629
abnormal myocardial fiber morphology J:209629
abnormal sarcomere morphology J:209629
abnormal skeletal muscle fiber mitochondrial morphology J:209629
abnormal skeletal muscle morphology J:209629
abnormal Z line morphology J:209629
blood vessel congestion J:209629
brain vacuoles J:209629
cardiac fibrosis J:209629
decreased cardiac muscle contractility J:209629
decreased mitochondrial number J:209629
dilated cardiomyopathy J:209629
enlarged heart J:209629
increased cardiac muscle glycogen level J:209629
increased cardiomyocyte apoptosis J:209629
increased skeletal muscle glycogen level J:209629
lethargy J:209629
neurodegeneration J:209629
premature death J:209629
respiratory distress J:209629
skeletal muscle endomysial fibrosis J:209629
skeletal muscle fiber degeneration J:209629
skeletal muscle fiber necrosis J:209629
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6 		abnormal mitochondrial crista morphology J:209629
abnormal mitochondrial morphology J:209629
abnormal mitochondrial physiology J:209629
abnormal myocardial fiber mitochondrial morphology J:209629
abnormal myocardial fiber morphology J:209629
abnormal sarcomere morphology J:209629
abnormal skeletal muscle fiber mitochondrial morphology J:209629
abnormal skeletal muscle morphology J:209629
abnormal Z line morphology J:209629
blood vessel congestion J:209629
brain vacuoles J:209629
cardiac fibrosis J:209629
decreased cardiac muscle contractility J:209629
decreased mitochondrial number J:209629
dilated cardiomyopathy J:209629
enlarged heart J:209629
increased cardiomyocyte apoptosis J:209629
increased skeletal muscle glycogen level J:209629
lethargy J:209629
neurodegeneration J:209629
premature death J:209629
respiratory distress J:209629
Cxcl12tm1.1Sjm/Cxcl12tm1.1Sjm
Ndor1Tg(UBC-cre/ERT2)1Ejb/?
involves: 129S/SvEv * C57BL/6 		decreased bone marrow cell number J:194748
decreased hematopoietic stem cell number J:194748
decreased leukocyte cell number J:194748
decreased lymphocyte cell number J:194748
Dcp2tm1Smoc/Dcp2tm1Smoc
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129S/SvEv * C57BL/6 		asthenozoospermia J:292283
decreased circulating testosterone level J:292283
decreased male germ cell number J:292283
decreased testis weight J:292283
increased circulating follicle stimulating hormone level J:292283
increased circulating luteinizing hormone level J:292283
increased male germ cell apoptosis J:292283
male infertility J:292283
Dido1tm3Cmar/Dido1tm3.1Cmar
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129S/SvEv * C57BL/6 		abnormal hepatocyte morphology J:328215
ataxia J:328215
decreased body weight J:328215
decreased testis weight J:328215
enlarged liver J:328215
impaired coordination J:328215
increased circulating alanine transaminase level J:328215
increased circulating aspartate transaminase level J:328215
increased circulating cholesterol level J:328215
increased hepatocyte karyomegaly J:328215
liver inflammation J:328215
male infertility J:328215
seizures J:328215
small testis J:328215
testis degeneration J:328215
Eif4btm1.1Smoc/Eif4btm1.1Smoc
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129 * C57BL/6 		decreased food intake J:311140
decreased leukocyte cell number J:311140
decreased locomotor activity J:311140
decreased lymphocyte cell number J:311140
decreased NK cell number J:311140
increased macrophage cell number J:311140
increased neutrophil cell number J:311140
increased susceptibility to induced colitis J:311140
increased susceptibility to Orthomyxoviridae infection J:311140
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality J:311140
lung inflammation J:311140
matted coat J:311140
premature death J:311140
small spleen J:311140
small thymus J:311140
weight loss J:311140
Epas1tm1Mcs/Epas1tm1.1Mcs
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129X1/SvJ * FVB/N 		abnormal hematopoietic system physiology J:119731
abnormal proerythroblast morphology J:119731
anemia J:119731
decreased erythrocyte cell number J:119731
decreased hematocrit J:119731
decreased hemoglobin content J:119731
enlarged spleen J:119731
reticulocytopenia J:119731
Esco1tm1.1Ge/Esco1tm1.1Ge
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129S2/SvPas * C57BL/6 * SJL 		abnormal mitosis J:296958
Esco2tm1.1Ge/Esco2tm1.1Ge
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129S2/SvPas * C57BL/6 * SJL 		abnormal mitosis J:296958
Foxo1tm1Flv/Foxo1tm1Flv
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 		increased interferon-gamma secretion J:189962
Ftotm1.1Rdc/Ftotm1.1Rdc
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL 		decreased body weight J:194922
decreased carbon dioxide production J:194922
decreased lean body mass J:194922
decreased respiratory quotient J:194922
normal homeostasis/metabolism phenotype J:194922
increased total body fat amount J:194922
premature death J:194922
Fustm1a(EUCOMM)Wtsi/Fustm1c(EUCOMM)Wtsi
Mapttm3.1(FUS)Neas/Mapt+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129 * C3H * C57BL/6 * C57BL/6N 		abnormal neuromuscular synapse morphology J:232167
Fustm1a(EUCOMM)Wtsi/Fustm1c(EUCOMM)Wtsi
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C3H * C57BL/6 * C57BL/6N 		normal nervous system phenotype J:232167
Gm30731tm1.1Dalm/Gm30731tm1.1Dalm
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129S/SvEv * C57BL/6 		abnormal neuronal stem cell physiology J:281278
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129X1/SvJ * C57BL/6 		abnormal pulmonary alveolus morphology J:264185
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 		alopecia J:256652
ataxia J:256652
enlarged lymph nodes J:256652
enlarged popliteal lymph nodes J:256652
impaired righting response J:256652
kyphosis J:256652
retarded hair growth J:256652
seizures J:256652
tremors J:256652
Gt(ROSA)26Sortm1Iaai/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 		abnormal bone marrow cell physiology J:196407
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 		decreased locomotor activity J:161393
impaired coordination J:161393
limb grasping J:161393
respiratory distress J:161393
Gt(ROSA)26Sortm2Iaai/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 		abnormal bone marrow cell physiology J:196407
Hif1atm3Rsjo/Hif1atm3Rsjo
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S1/Sv * 129X1/SvJ 		normal immune system phenotype J:119731
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
B6.Cg-Ndor1Tg(UBC-cre/ERT2)1Ejb Igf1rtm1Jcbr 		abnormal susceptibility to injury induced morbidity/mortality J:241920
decreased airway responsiveness J:241924
decreased collagen level J:241924
decreased respiratory mucosa goblet cell number J:241924
decreased susceptibility to injury J:241920
decreased susceptibility to type I hypersensitivity reaction J:241924
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 		abnormal bronchiole epithelium morphology J:221618
abnormal pulmonary alveolar parenchyma morphology J:221618
abnormal spermatogenesis J:221618
azoospermia J:221618
decreased body weight J:221618
decreased testis weight J:221618
increased hepatocyte proliferation J:221618
oligozoospermia J:221618
postnatal growth retardation J:221618
normal reproductive system phenotype J:221618
small seminiferous tubules J:221618
Il2tm1.1Kasm/Il2tm1.1Kasm
Ndor1Tg(UBC-cre/ERT2)1Ejb/?
involves: 129S/SvEv * C57BL/6 		abnormal cellular respiration J:190168
decreased circulating interleukin-17 level J:190168
normal immune system phenotype J:190168
Kitltm2.1Sjm/Kitltm2.1Sjm
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 * C57BL/Ka * SJL 		abnormal bone marrow cell physiology J:180431
anemia J:180431
decreased bone marrow cell number J:180431
decreased erythrocyte cell number J:180431
decreased hematopoietic cell number J:180431
liver hypoplasia J:180431
Kmt2btm1.1Afst/Kmt2btm1.1Afst
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129P2/OlaHsd * 129S/Sv * C3H/HeH * C57BL/6 		normal homeostasis/metabolism phenotype J:203736
Lcn6tm1.1Ylzh/Lcn6tm1.1Ylzh
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129S/SvEv * C57BL/6 		abnormal calcium ion homeostasis J:256079
abnormal sperm physiology J:256079
premature acrosome reaction J:256079
normal reproductive system phenotype J:256079
Lin28atm1Gqda/Lin28atm1.1Gqda
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N 		decreased body length J:199720
decreased body size J:199720
normal growth/size/body region phenotype J:199720
Lin28btm1Gqda/Lin28btm1.1Gqda
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S4/SvJae * C57BL/6 		decreased body size J:199720
normal growth/size/body region phenotype J:199720
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Trp53tm1Brd/Trp53tm1Brd
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N 		tumor regression J:223417
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rragatm2Dmsa/Rragatm2Dmsa
involves: 129S/SvEv * 129S4/SvJae * C57BL/6 		abnormal intestine apoptosis J:213516
decreased B cell number J:213516
enlarged spleen J:213516
increased apoptosis J:213516
increased lymphoma incidence J:213516
increased monocyte cell number J:213516
myeloid hyperplasia J:213516
premature death J:213516
weight loss J:213516
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rnpc3tm1c(EUCOMM)Wtsi/Rnpc3+
involves: 129S/SvEv * C57BL/6 * C57BL/6N 		no abnormal phenotype detected J:267519
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rnpc3tm1c(EUCOMM)Wtsi/Rnpc3tm1c(EUCOMM)Wtsi
involves: 129S/SvEv * C57BL/6 * C57BL/6N 		abnormal digestive system morphology J:267519
abnormal enterocyte proliferation J:267519
abnormal esophageal squamous epithelium morphology J:267519
abnormal intestinal epithelium morphology J:267519
abnormal intestinal mucosa morphology J:267519
abnormal large intestine crypts of Lieberkuhn morphology J:267519
abnormal skin morphology J:267519
abnormal small intestinal crypt cell proliferation J:267519
abnormal small intestine crypts of Lieberkuhn morphology J:267519
abnormal stomach glandular epithelium morphology J:267519
anemia J:267519
decreased erythrocyte cell number J:267519
decreased leukocyte cell number J:267519
decreased lymphocyte cell number J:267519
decreased monocyte cell number J:267519
decreased small intestinal villus height J:267519
decreased thymus weight J:267519
disheveled coat J:267519
epidermal atrophy J:267519
esophageal inflammation J:267519
hunched posture J:267519
increased small intestinal crypt cell apoptosis J:267519
moribund J:267519
sebaceous gland atrophy J:267519
small intestinal inflammation J:267519
thrombocytopenia J:267519
thymus atrophy J:267519
thymus cortex atrophy J:267519
thymus medulla atrophy J:267519
weight loss J:267519
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Stag2tm1.1Alos/Y
involves: 129S6/SvEvTac * C57BL/6NCrl 		abnormal enterocyte proliferation J:298088
abnormal hematopoietic stem cell physiology J:298088
abnormal intestine morphology J:298088
abnormal mitosis J:298088
cellular necrosis J:298088
decreased body weight J:298088
decreased fibroblast proliferation J:298088
normal hematopoietic system phenotype J:298088
increased fibroblast apoptosis J:298088
normal neoplasm J:298088
premature death J:298088
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Stag2tm1.1Alos/Stag2tm1.1Alos
involves: 129S6/SvEvTac * C57BL/6NCrl 		abnormal enterocyte proliferation J:298088
abnormal hematopoietic stem cell physiology J:298088
abnormal intestine morphology J:298088
abnormal mitosis J:298088
cellular necrosis J:298088
decreased body weight J:298088
decreased fibroblast proliferation J:298088
hematopoietic system phenotype J:298088
increased fibroblast apoptosis J:298088
neoplasm J:298088
premature death J:298088
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rpl11tm1.1Srn/Rpl11+
involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1 		abnormal erythropoiesis J:292575
abnormal proerythroblast morphology J:292575
anemia J:292575
decreased erythroblast number J:292575
decreased erythrocyte cell number J:292575
decreased hemoglobin content J:292575
increased incidence of tumors by ionizing radiation induction J:292575
increased mortality induced by gamma-irradiation J:292575
macrocytosis J:292575
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rpl11tm1.1Srn/Rpl11tm1.1Srn
involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1 		abnormal bone marrow cell morphology/development J:292575
abnormal intestine morphology J:292575
anemia J:292575
decreased erythroblast number J:292575
increased liver iron level J:292575
premature death J:292575
Nr6a1tm1c(EUCOMM)Wtsi/Nr6a1tm1c(EUCOMM)Wtsi
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 * C57BL/6N * SJL 		normal reproductive system phenotype J:204241
Nsmce2tm2.1Ofc/Nsmce2tm2.1Ofc
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 * SJL 		abnormal cell nucleus morphology J:227197
abnormal coat/hair pigmentation J:227197
abnormal intestinal epithelium morphology J:227197
abnormal mitosis J:227197
abnormal skin pigmentation J:227197
abnormal thymus physiology J:227197
anemia J:227197
decreased embryo size J:227197
decreased total body fat amount J:227197
elevated level of mitotic sister chromatid exchange J:227197
mitotic nondisjunction J:227197
premature aging J:227197
premature death J:227197
Pdzrn3tm1.1Ysa/Pdzrn3tm1.1Ysa
Ndor1Tg(UBC-cre/ERT2)1Ejb/?
involves: 129S/SvEv * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj 		abnormal brain vasculature morphology J:222522
abnormal extraembryonic tissue morphology J:222522
abnormal placenta morphology J:222522
abnormal placental labyrinth vasculature morphology J:222522
abnormal vitelline artery morphology J:222522
abnormal vitelline vasculature morphology J:222522
decreased placental labyrinth size J:222522
disorganized yolk sac vascular plexus J:222522
normal embryo phenotype J:222522
embryonic growth retardation J:222522
embryonic lethality during organogenesis J:222522
normal nervous system phenotype J:222522
Phf2tm1.2Yima/Phf2tm1.2Yima
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 * C57BL/6J * SJL 		abnormal adipose tissue development J:198329
Rad51tm1Csha/Rad51tm1Csha
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129S/Sv * C57BL/6J 		abnormal double-strand DNA break repair J:324159
abnormal male meiosis J:324159
abnormal spermatocyte morphology J:324159
abnormal spermatogenesis J:324159
decreased male germ cell number J:324159
decreased testis weight J:324159
increased male germ cell apoptosis J:324159
small testis J:324159
Sh2d1atm1.1Knic/Y
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129X1/SvJ * C57BL/6 		abnormal NK T cell physiology J:196692
decreased circulating interleukin-4 level J:196692
decreased interferon-gamma secretion J:196692
normal immune system phenotype J:196692
Sh2d1atm1.1Knic/Sh2d1atm1.1Knic
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129X1/SvJ * C57BL/6 		abnormal NK T cell physiology J:196692
decreased circulating interleukin-4 level J:196692
decreased interferon-gamma secretion J:196692
normal immune system phenotype J:196692
Stk11tm1.1Sjm/Stk11tm1.1Sjm
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * C57BL/6 * SJL 		abnormal bone marrow cell physiology J:165090
Stk26tm1.1Zzh/Stk26+
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL 		increased incidence of tumors by chemical induction J:289548
Stk26tm1.1Zzh/Stk26tm1.1Zzh
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL 		increased incidence of tumors by chemical induction J:289548
Wnt5atm1.1Tpy/Wnt5atm1.1Tpy
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S/SvEv * 129S1/Sv * C57BL/6 		abnormal intestine regeneration J:187747
abnormal wound healing J:187747
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/16/2024
MGI 6.23 		The Jackson Laboratory